Apeloa Pharmaceutical Co.,Ltd (000739.SZ)
CNY 13.72
(0.66%)
CNY 13.72
(0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.03 Billion | 1.32 Billion | 611.74 Million | 1.05 Billion | 1.36 Billion | 832.69 Million |
| Net Income | 1.05 Billion | 989.17 Million | 955.55 Million | 816.73 Million | 553.4 Million | 370.56 Million |
| Depreciation & Amortization | 558.96 Million | 389.43 Million | 358.64 Million | 353.82 Million | 353.54 Million | 329.4 Million |
| Deferred income taxes | 3.64 Million | -104 Million | -13.98 Million | 18.44 Million | -7.77 Million | 11.66 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -777.93 Million | -165.81 Million | -682.12 Million | -74.13 Million | 360.71 Million | 40.73 Million |
| Other non-cash items | 2.12 Billion | 113.32 Million | -20.32 Million | -36.89 Million | 92.4 Million | 91.98 Million |
| Investing Cash Flow | -676.42 Million | -591.3 Million | -515.39 Million | 106.36 Million | -440.83 Million | -178.97 Million |
| Investments in PPE | -630.46 Million | -509.1 Million | -701.92 Million | -317.11 Million | -31.84 Million | -81.62 Million |
| Acquisitions | 39.73 Million | 12.21 Million | 3.87 Million | 16.68 Million | -980 Thousand | 16.34 Million |
| Investment purchases | -172.94 Million | -389.02 Million | -446.92 Million | -424.5 Million | -864 Million | -356.5 Million |
| Sales/Maturities of investments | 87.25 Million | 383.24 Million | 559.1 Million | 821.82 Million | 516.85 Million | 257.08 Million |
| Other Investing Activities | 1.00 | -88.63 Million | 70.47 Million | 9.47 Million | -60.86 Million | -14.27 Million |
| Financing Cash Flow | -301.85 Million | -196.08 Million | -204.32 Million | 78.74 Million | -706.15 Million | -593.74 Million |
| Debt repayment | -96.51 Million | -712.71 Million | -698.2 Million | -204 Million | -944.1 Million | -1.63 Billion |
| Dividends payments | -347.28 Million | -335.87 Million | -286.38 Million | -194.45 Million | -129.63 Million | -119.83 Million |
| Common Stock Repurchased | - | -200.2 Million | - | - | - | - |
| Common Stock Issuance | - | 200.2 Million | - | - | - | - |
| Other Financing Activities | 141.94 Million | 879.42 Million | 795.79 Million | 484.09 Million | 380 Million | 1.16 Billion |
| Accounts receivables | -571.62 Million | -1.1 Billion | -851.43 Million | -176.76 Million | -294.39 Million | -58.91 Million |
| Accounts payables | 130.16 Million | 1.64 Billion | 373.37 Million | 201.09 Million | 787.78 Million | 295.64 Million |
| Inventory | -373.34 Million | -603.06 Million | -190.08 Million | -116.91 Million | -124.9 Million | -207.46 Million |
| Other working capital | 36.86 Million | -104 Million | -13.98 Million | 18.44 Million | -7.77 Million | 248.19 Million |
| Cash at beginning of period | 3.55 Billion | 1.79 Billion | 1.92 Billion | 718.07 Million | 501.72 Million | 434.14 Million |
| Cash at end of period | 3.58 Billion | 2.38 Billion | 1.79 Billion | 1.92 Billion | 718.07 Million | 501.36 Million |
| Capital Expenditure | -630.46 Million | -509.1 Million | -701.92 Million | -317.11 Million | -31.84 Million | -81.62 Million |
| Effect of forex changes on cash | 27.49 Million | 44.04 Million | -17.31 Million | -38.27 Million | 3.27 Million | 7.25 Million |
| Net cash flow / Change in cash | 27.82 Million | 582.75 Million | -125.28 Million | 1.2 Billion | 216.35 Million | 67.21 Million |
| Free Cash Flow | 400.89 Million | 816.99 Million | -90.17 Million | 742.41 Million | 1.32 Billion | 751.06 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 244.8 Million | 381.12 Million | 243.71 Million | 1.05 Billion | 203.99 Million | 250.27 Million |
| Depreciation & Amortization | - | 143.66 Million | 143.66 Million | 558.96 Million | 137.82 Million | -280.3 Million |
| Deferred income taxes | - | - | - | 3.64 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -317.89 Million | - | -777.93 Million | -908.1 Million | 447.92 Million |
| Other non-cash items | -59.88 Million | 463.19 Million | 36.4 Million | 2.12 Billion | 749.1 Million | -311.73 Million |
| Investing Cash Flow | -143.27 Million | -32.62 Million | -188.14 Million | -676.42 Million | -215.99 Million | -231.49 Million |
| Investments in PPE | -145.35 Million | -29.97 Million | -195.49 Million | -630.46 Million | -213.42 Million | -194.93 Million |
| Acquisitions | 829.45 Thousand | 1.81 Million | 7.6 Million | 39.73 Million | 8.84 Million | 108.15 Thousand |
| Investment purchases | -199.53 Million | -6 Million | - | -172.94 Million | -49.74 Million | -73.2 Million |
| Sales/Maturities of investments | 209.81 Million | - | - | 87.25 Million | 41.98 Million | 37.25 Million |
| Other Investing Activities | 201.61 Million | 1.54 Million | -251.42 Thousand | 1.00 | -3.65 Million | -727.56 Thousand |
| Financing Cash Flow | -54.23 Million | -516.32 Million | 37.52 Million | -301.85 Million | 7.85 Million | -70.9 Million |
| Debt repayment | -35.9 Million | -16.05 Million | -210 Million | -96.51 Million | -21.71 Million | -383 Million |
| Dividends payments | -8.77 Million | -380.45 Million | -11.71 Million | -347.28 Million | -347.28 Million | -11.66 Million |
| Common Stock Repurchased | 145.67 Million | -145.67 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.55 Million | -379.69 Million | -761.41 Thousand | 141.94 Million | 376.85 Million | 323.76 Million |
| Accounts receivables | - | -650.38 Million | - | -571.62 Million | -571.62 Million | 352.53 Million |
| Accounts payables | - | - | - | 130.16 Million | - | - |
| Inventory | - | 332.49 Million | - | -373.34 Million | -373.34 Million | 95.38 Million |
| Other working capital | - | - | - | 36.86 Million | 36.86 Million | - |
| Cash at beginning of period | 2.77 Billion | 3.71 Billion | 2.46 Billion | 3.55 Billion | 3.7 Billion | 2.69 Billion |
| Cash at end of period | 2.73 Billion | 3.94 Billion | 2.59 Billion | 3.58 Billion | 3.58 Billion | 2.49 Billion |
| Capital Expenditure | -145.35 Million | -29.97 Million | -195.49 Million | -630.46 Million | -213.42 Million | -194.93 Million |
| Effect of forex changes on cash | -26.74 Million | 24.09 Million | 7.08 Million | 27.49 Million | -7.65 Million | -2.47 Million |
| Net cash flow / Change in cash | -39.32 Million | 231.94 Million | 136.58 Million | 27.82 Million | -124.33 Million | -198.69 Million |
| Free Cash Flow | 39.57 Million | 670.67 Million | 84.63 Million | 400.89 Million | -30.59 Million | -88.76 Million |
EXICOM
HLG
RKDL
603337
SVT
LOCO